FindTrial
Sign In

Concentration of a blood marker called Serum Ferritin in early Pregnancy and risk of subsequent development of Diabetes in Second Trimester of pregnancy

Serum Ferritin Concentration in early Pregnancy and risk of subsequent development of Gestational Diabetes Mellitus - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/06/069153
Enrollment
150
Registered
2024-06-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O098- Supervision of other high risk pregnancies

Interventions

Intervention1: Nil: Nil

Sponsors

Kasturba Medical College Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Singleton Pregnancy First Trimester Pregnant Women

Exclusion criteria

Exclusion criteria: Multiple Pregnancies Overt Diabetics Iron Deficiency on treatment Presence of any Hemoglobinopathies Acute/Chronic Inflammatory Conditions

Design outcomes

Primary

MeasureTime frame
If a strong association is proven between Serum Ferritin Assay in first trimester and risk of development of Gestational Diabetes Mellitus , then it can be used as a predictive marker for GDMTimepoint: 24weeks of Gestation—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactAditi Bharuka

Kasturba Medical College, Manipal

Rekha.upadhya@manipal.edu9986143120

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026